Oxford Biomedica plc
Oxford Biomedica plc (LSE: OXB) is trading at £5.07, about ₹644 at today's GBP/INR rate, as of 25 Sep 2026, 11:35 AM ET, up 3.47% today. Indian residents can buy Oxford Biomedica from India on Paasa under the RBI's Liberalised Remittance Scheme.
Quote
Today's low
£4.84
Today's high
£5.07
52 week low
£4.20
52 week high
£9.62
OXB opened at £4.96, closed previously at £4.90, and has traded between £4.20 and £9.62 over the past 52 weeks.
About
Oxford Biomedica plc is a biopharmaceutical firm focused on the discovery, advancement, and sophisticated bioprocessing of innovative cell and gene therapies. Operating globally, with a strong presence across Europe, the company organizes its activities into two segments: Platform and Product. Its proprietary LentiVector platform technology facilitates the integration of genes into non-dividing cells, such as neurological cells in the brain and retinal cells in the eye, and can incorporate diverse therapeutic genes. The company's developmental pipeline includes promising candidates like Axo-Lenti-PD, a gene-based treatment for Parkinson's disease. Other pre-clinical stage programs feature OXB-302, targeting haematological tumors, and OXB-401, OXB-40X, and OXB-40Y, all addressing liver indications. Oxford Biomedica maintains numerous strategic alliances with prominent pharmaceutical entities such as Novartis, Bristol Myers Squibb, Sio Gene Therapies, Orchard Therapeutics, Boehringer Ingelheim, the UK Cystic Fibrosis Gene Therapy Consortium, Immatics, Arcellx, and the Vaccines Manufacturing and Innovation Centre. Additionally, it engages in research collaborations, including a partnership with Circularis Biotechnologies to identify novel tissue-specific promoters for in vivo lentiviral gene therapy, Virica Biotech for scaling viral medicines, Isolere Bio for enhancing downstream manufacturing efficiencies of biologics, and BiologIC Technologies for utilizing a novel biocomputer system in viral vector development. Founded in 1995, Oxford Biomedica plc is headquartered in Oxford, United Kingdom.
Key statistics
Avg. volume
629.55K
Market cap
£613.66M
P/E Ratio
-14.67
Price-to-sales ratio
3.50
Enterprise value
£697.02M
Free cash flow yield
-5.92%
Debt-to-equity ratio
2.73
Return on equity
-54.51%
ROIC
-11.59%
Beta
1.09
Dividend yield
0.00%
Last dividend
£0.00
Financial overview
Revenue
£168.74M
Earnings per share
-£0.27
Free cash flow
-£10.21M
Net profit margin
-23.23%
Gross margin
36.03%
EBITDA
-£9.12M
Revenue growth
31.01%
Similar securities
This is not an investment recommendation
How to buy Oxford Biomedica from India
Indian residents can buy Oxford Biomedica shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.
Open a Paasa account
Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Add funds under LRS
Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars and then to GBP.
Search for Oxford Biomedica and place an order
Find Oxford Biomedica by name or by its ticker, OXB, and choose an order type. Oxford Biomedica trades 12:30 pm – 9:00 pm IST; orders can only execute during that window.
Track holdings and download tax reports
Follow your Oxford Biomedica position in GBP and INR. Oxford Biomedica pays no dividend today, so your filing is the capital-gains statement plus the Schedule FA holding line.
Read the full guide: how to invest in Oxford Biomedica from India
Trading and taxes when buying Oxford Biomedica from India
Trading and limits
- Trading hours
- 8:00 am – 4:30 pm UK
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- NoneOxford Biomedica does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained
- Transaction tax
- The UK charges 0.5% Stamp Duty Reserve Tax when buying direct company shares electronically on the LSE; ETFs and UCITS funds do not attract it.
- Estate or inheritance tax
- May applyShares in UK-incorporated companies are UK-situs assets and fall within UK Inheritance Tax, charged at 40% above the £325,000 threshold for non-residents.Estate tax explained
Custody. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
FAQs
Can Indian residents buy Oxford Biomedica stock?
Yes. Oxford Biomedica (OXB) has been listed on the London Stock Exchange since 1996, in the Biotechnology industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars and then to GBP. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
How much does one Oxford Biomedica share cost in rupees?
One Oxford Biomedica share is £5.07 — about ₹644 at a GBP/INR rate of 126.99 on 26 Sep 2026. Both the Oxford Biomedica price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for buying Oxford Biomedica from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.
How are gains on Oxford Biomedica shares taxed in India?
Non-residents are exempt from UK capital gains tax on the disposal of listed shares, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the GBP/INR rate on the purchase and the sale date, so the rupee move counts alongside the Oxford Biomedica price. Paasa issues a capital-gains statement for your return.
Does Oxford Biomedica pay a dividend?
No. Oxford Biomedica does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one — dividends are taxed at your slab rate in India — and Paasa's dividend report would show the gross amount and any tax withheld.
When can I trade Oxford Biomedica from India?
The London Stock Exchange trades 12:30 pm – 9:00 pm IST in Indian time. The window shifts to 1:30 pm – 10:00 pm IST when the UK is on standard time. Orders can only execute during that window.
Is there estate or inheritance tax on Oxford Biomedica shares held from India?
Shares in UK-incorporated companies are UK-situs assets and fall within UK Inheritance Tax, charged at 40% above the £325,000 threshold for non-residents. It applies to your overall holdings in that jurisdiction rather than to any one position.
Are there transaction taxes when buying Oxford Biomedica?
The UK charges 0.5% Stamp Duty Reserve Tax when buying direct company shares electronically on the LSE; ETFs and UCITS funds do not attract it. This is charged by the market, not by Paasa.
Do I have to declare Oxford Biomedica shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Oxford Biomedica holding, its cost and its closing value.
How do I sell Oxford Biomedica and bring the money back to India?
You sell during market hours (12:30 pm – 9:00 pm IST) and the proceeds settle in GBP in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.